US equities
|
MU
$983.23
▲+5.86%
META
$612.49
▼-1.24%
GOOGL
$324.89
▲+1.34%
NVDA
$215.38
▼-1.17%
MSFT
$531.01
▼-0.06%
TSLA
$404.22
▼-0.80%
SPCX
$145.23
▼-2.25%
SNDK
$1,404.77
▲+7.66%
MU
$983.23
▲+5.86%
META
$612.49
▼-1.24%
GOOGL
$324.89
▲+1.34%
NVDA
$215.38
▼-1.17%
MSFT
$531.01
▼-0.06%
TSLA
$404.22
▼-0.80%
SPCX
$145.23
▼-2.25%
SNDK
$1,404.77
▲+7.66%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
CNS Pharmaceuticals, Inc. - Common Stock
(NQ:
CNSP
)
4.510
-0.570 (-11.22%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CNS Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
New Machine Learning Model Predicts Cancer Severity, Aids Treatment Planning
July 21, 2025
Via
Investor Brand Network
TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces 1-for-12 Reverse Stock Split Effective July 22
July 18, 2025
Via
Investor Brand Network
CNS Pharmaceuticals Announces Reverse Stock Split
July 18, 2025
Via
ACCESS Newswire
New Study Suggests Concussions Could Lead to Higher Risks of Brain Cancer
July 10, 2025
Via
Investor Brand Network
InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Lead Program in Virtual CEO Segment
July 09, 2025
Via
Investor Brand Network
CNS Pharmaceuticals Participates in Virtual Investor CEO Connect Segment
July 09, 2025
Via
ACCESS Newswire
Discover the top movers in Thursday's pre-market session.
↗
July 03, 2025
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
July 03, 2025
Via
Benzinga
Research Links Key Proteins to the Growth of Brain Tumors
June 27, 2025
Via
Investor Brand Network
New Scanning Method Could Improve How Brain Tumors are Treated
June 25, 2025
Via
Investor Brand Network
TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights GBM Treatment Insights in KOL Segment Featuring Dr. Erin Dunbar
June 24, 2025
Via
Investor Brand Network
CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment Discussing Glioblastoma Multiforme (GBM) and Lead Product Candidate TPI 287
June 24, 2025
Via
ACCESS Newswire
New Study Shows TTFields Amplify Immune Attack Against Brain Cancer
June 13, 2025
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present Promising Glioblastoma Data at Brain Tumor Biotech Summit
June 05, 2025
Via
Investor Brand Network
CNS Pharmaceuticals' Chief Medical Officer, Sandra Silberman, MD, PhD to Present at the 2025 Brain Tumor Biotech Summit
June 05, 2025
Via
ACCESS Newswire
Hundreds Sue Pfizer Over Birth Control Jabs Linked to Brain Tumors
June 04, 2025
Via
Investor Brand Network
Topics
Lawsuit
Study Finds That Kids, Young People Wait Longer to Receive a Cancer Diagnosis
June 03, 2025
Via
Investor Brand Network
Experts Say New Test for Brain Tumors is a Game-Changer
May 22, 2025
Via
Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q1 Loss, Highlights Progress on TPI 287 for Brain Cancer
May 16, 2025
Via
Investor Brand Network
CNS Pharmaceuticals Stock Declines On Wider Q1 Loss: But Retail Stays Unmoved
↗
May 16, 2025
The company intends to commence the phase 2 study of its lead program, TPI 287, to treat Glioblastoma Multiforme (GBM) by year-end.
Via
Stocktwits
CNS Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 16, 2025
Via
ACCESS Newswire
Simple Hand Motion Test Could Reveal Undetected Brain Tumor
May 14, 2025
Via
Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Prices $5 Million Public Offering with Institutional Investor
May 14, 2025
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
May 13, 2025
Via
Benzinga
There are notable gap-ups and gap-downs in today's session.
↗
May 13, 2025
Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via
Chartmill
Which stocks are moving before the opening bell on Tuesday?
↗
May 13, 2025
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.
Via
Chartmill
CNS Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
May 13, 2025
Via
ACCESS Newswire
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures Orphan Drug Designation Transfer for TPI 287 in Brain Cancer Indications
May 13, 2025
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
May 13, 2025
Via
Benzinga
CNS Pharmaceuticals Acquires Orphan Drug Designation for Novel, Late Stage Abeotaxane, TPI 287
May 13, 2025
Via
ACCESS Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
